Physician profile
George Georges
NPI 1700173481
$856.91
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $857.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $116.00 | 2019 | |
| Shire North American Group INC | $95.50 | 2019 | |
| Lilly USA, LLC | $78.97 | 2019 | |
| Abbott Laboratories | $66.62 | 2019 | |
| Amgen INC. | $60.85 | 2019 | |
| Janssen Pharmaceuticals, INC | $56.60 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $49.14 | 2019 | |
| Sanofi-Aventis U.S. LLC | $36.28 | 2019 | |
| Valeritas, INC. | $35.36 | 2019 | |
| Pfizer INC. | $29.12 | 2019 | |
| Becton, Dickinson and Company | $24.20 | 2019 | |
| Merck Sharp & Dohme LLC | $23.52 | 2019 | |
| Ibsa Pharma INC. | $18.34 | 2019 | |
| Tandem Diabetes Care, INC. | $17.83 | 2019 | |
| Abbvie INC. | $16.32 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.27 | 2019 | |
| Dexcom, INC. | $15.89 | 2019 | |
| Medtronic Minimed, INC. | $15.72 | 2019 | |
| Corcept Therapeutics | $15.65 | 2019 | |
| Amarin Pharma, INC. | $15.26 | 2019 | |
| Aytu Biopharma, INC. | $14.60 | 2019 | |
| Antares Pharma, INC. | $14.31 | 2019 | |
| Insulet Corporation | $12.91 | 2019 | |
| Amneal Pharmaceuticals LLC | $11.65 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Georges listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.